SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-018476
Filing Date
2023-05-08
Accepted
2023-05-08 08:00:39
Documents
62
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q alrn-20230331.htm   iXBRL 10-Q 1508014
2 EX-10.1 alrn-ex10_1.htm EX-10 137122
3 EX-10.2 alrn-ex10_2.htm EX-10 76744
4 EX-31.1 alrn-ex31_1.htm EX-31 17438
5 EX-31.2 alrn-ex31_2.htm EX-31 16903
6 EX-32.1 alrn-ex32_1.htm EX-32 10868
7 EX-32.2 alrn-ex32_2.htm EX-32 9239
  Complete submission text file 0000950170-23-018476.txt   6365169

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alrn-20230331_def.xml EX-101.DEF 125098
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alrn-20230331_cal.xml EX-101.CAL 33583
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alrn-20230331_lab.xml EX-101.LAB 345006
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alrn-20230331_pre.xml EX-101.PRE 244021
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alrn-20230331.xsd EX-101.SCH 37000
56 EXTRACTED XBRL INSTANCE DOCUMENT alrn-20230331_htm.xml XML 1152116
Mailing Address 738 MAIN STREET UNIT 398 WALTHAM MA 02451
Business Address 738 MAIN STREET UNIT 398 WALTHAM MA 02451 617-995-0900
AILERON THERAPEUTICS INC (Filer) CIK: 0001420565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38130 | Film No.: 23895907
SIC: 2834 Pharmaceutical Preparations